Biocon Biologics to offer 15 pc stake to Serum Institute Life Sciences at valuation of USD 4.9 bn
Biocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about USD 4.9 billion.